Trellus Management Company’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-841
| Closed | -$16K | – | 72 |
|
2021
Q1 | $16K | Sell |
841
-43,333
| -98% | -$824K | 0.01% | 54 |
|
2020
Q4 | $1.28M | Buy |
44,174
+16,412
| +59% | +$475K | 1.06% | 20 |
|
2020
Q3 | $1.05M | Buy |
27,762
+3,333
| +14% | +$125K | 1.07% | 23 |
|
2020
Q2 | $813K | Sell |
24,429
-5,320
| -18% | -$177K | 0.88% | 25 |
|
2020
Q1 | $1.06M | Hold |
29,749
| – | – | 1.9% | 13 |
|
2019
Q4 | $1.31M | Buy |
29,749
+9,940
| +50% | +$438K | 2.2% | 12 |
|
2019
Q3 | $446K | Buy |
19,809
+1,942
| +11% | +$43.7K | 0.45% | 38 |
|
2019
Q2 | $750K | Buy |
17,867
+1,824
| +11% | +$76.6K | 1.02% | 25 |
|
2019
Q1 | $496K | Buy |
16,043
+4,751
| +42% | +$147K | 0.94% | 34 |
|
2018
Q4 | $290K | Buy |
11,292
+1,103
| +11% | +$28.3K | 0.66% | 35 |
|
2018
Q3 | $330K | Buy |
10,189
+1,573
| +18% | +$50.9K | 0.48% | 43 |
|
2018
Q2 | $302K | Buy |
+8,616
| New | +$302K | 0.45% | 46 |
|